Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prove effect of glucose reduction that CKD-501 and metformin
combination treatment group is non inferiority compare to pioglitazone and metformin
combination.